Sign in
TerminatedNo phase

Drainless Robot-assisted Minimally Invasive Esophagectomy

Key facts

Who runs it
Technische Universität Dresden
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
49 people enrolled
Started
19 Apr 2023
Ended
21 May 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Early removal of chest drain
  • Chest drain
Record updated
13 June 2024
Why it stopped
Following a safety analysis and assessment of the complications encountered by external experts, it was decided to terminate recruitment prematurely

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (15)Hide the full registry criteria

Who can take part

  • Patients scheduled for elective RAMIE for esophageal cancer with intrathoracic esophagogastrostomy (Ivor-Lewis)
  • American Society of Anesthesiologists (ASA) score ≤ III
  • Eastern Cooperative of Oncology Group (ECOG) status ≤ II
  • Patient suitable for both surgical techniques
  • Ability of subject to understand character and individual consequences of the clinical trial
  • Written informed consent

Who cannot take part

  • Simultaneous lung resection
  • Chronic pain syndromes requiring routine analgesics
  • Presence of contraindications to the use of epidural anesthesia (e.g. coagulopathies, anticoagulation or allergies)
  • Open esophagectomy (either abdominal or during the thoracic part)
  • Emergency operations
  • ASA IV
  • ECOG > II
  • Participation in an interventional trial, which interferes with the outcome
  • Impaired mental state

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is the evaluation of two different chest drain management strategies in patients undergoing robot-assisted minimally invasive esophagectomy (RAMIE) for esophageal cancer with regard to perioperative complications until discharge.The primary objective of the study is to investigate whether the intensity of postoperative pain can be significantly reduced by avoiding thoracic drains after RAMIE. We assume that this will influence secondary endpoints such as early recovery and length of hospital stay.

The 2 groups in the trial

  • A - Early removal of chest drainTreatment being tested

    Treatment: Early removal of chest drain

  • B - ControlOther group

    Treatment: Chest drain

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
13 June 2024